Related Experiment Videos
[Amyloidosis in systemic lupus erythematosus]
Klinicheskaia Meditsina
|February 1, 1992
Summary
Systemic lupus erythematosus (SLE) can be associated with renal amyloidosis, particularly in patients with long-standing disease and those undergoing long-term immunosuppression. This condition involves AL-protein deposits in the kidneys, impacting treatment strategies.
Area of Science:
- Nephrology
- Rheumatology
- Pathology
Background:
- Renal amyloidosis is a serious complication that can affect patients with various underlying conditions.
- Systemic lupus erythematosus (SLE) is an autoimmune disease with diverse clinical manifestations, including kidney involvement.
Observation:
- A study observed 26 cases of renal amyloidosis, finding a 7% association with SLE.
- Amyloidosis in SLE patients was linked to long disease duration and prolonged immunosuppressive therapy.
Findings:
- Histochemical analysis revealed AL-protein deposits in renal glomeruli, resistant to potassium permanganate.
- These findings suggest the potential synthesis and deposition of AL-protein, characteristic of primary amyloidosis, in SLE patients.
Implications:
- Diagnosing amyloidosis in SLE patients during their lifetime is crucial for effective management.
- Considering amyloidosis is important when selecting therapeutic policies and evaluating immunosuppressive therapy for SLE.